Cerapedics Overview
- Year Founded
-
2001

- Status
-
Private
- Employees
-
206

- Latest Deal Type
-
Debt
- Latest Deal Amount
-
$2.34M
- Investors
-
8
Cerapedics General Information
Description
Developer of ortho-biological technology intended to provide bone graft substitute for use in spinal fusion surgery and other orthopedic procedures. The company's technology is focused on developing and commercializing novel biologic products that incorporate a small peptide as an attachment factor to stimulate the natural bone healing process, enabling physicians to support safer and predictable bone formation compared to commercially available bone growth factors.
Contact Information
Website
www.cerapedics.comCorporate Office
- 11025 Dover Street
- Suite 1600
- Westminster, CO 80021
- United States
Corporate Office
- 11025 Dover Street
- Suite 1600
- Westminster, CO 80021
- United States
Cerapedics Timeline
Cerapedics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
15. Debt - General | 30-Sep-2023 | $2.34M | Completed | Generating Revenue | ||
14. Debt - General | 27-Dec-2022 | Completed | Generating Revenue | |||
13. Later Stage VC (Series F) | 18-Feb-2022 | Completed | Generating Revenue | |||
12. Secondary Transaction - Private | 01-Aug-2021 | Completed | Generating Revenue | |||
11. Debt - General | 22-Mar-2019 | Completed | Generating Revenue | |||
10. Later Stage VC (Series E) | 06-Jul-2018 | Completed | Generating Revenue | |||
9. Later Stage VC (Series D) | 01-Jul-2017 | Completed | Generating Revenue | |||
8. Debt - General | 19-Apr-2017 | Completed | Generating Revenue | |||
7. Debt - General | 22-Apr-2016 | $7.63M | $73.1M | Completed | Generating Revenue | |
6. Later Stage VC (Series C) | 23-Feb-2015 | $8M | $65.5M | Completed | Generating Revenue |
Cerapedics Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series F | ||||||||
Series E | ||||||||
Series D | ||||||||
Series C | ||||||||
Series B | 13,256,314 | $0.010000 | 7% | $1.37 | $1.37 | 1x | $1.37 | 10.68% |
Series A | 14,457,000 | $0.010000 | 7% | $1 | $1 | 1x | $1 | 11.65% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Cerapedics Comparisons
Industry
Financing
Details
Cerapedics Competitors (16)
One of Cerapedics’s 16 competitors is IlluminOss, a Private Equity-Backed company based in East Providence, RI.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
IlluminOss | Private Equity-Backed | East Providence, RI | ||||
Encoll | Corporation | Fremont, CA | ||||
Spine Wave | Venture Capital-Backed | Shelton, CT | ||||
MicroCures | Venture Capital-Backed | Santa Cruz, CA | ||||
Centrexion Therapeutics | Venture Capital-Backed | Boston, MA |
Cerapedics Patents
Cerapedics Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2023321898-A1 | Devices and methods for ameliorating implant-induced inflammation | Pending | 11-Aug-2022 | ||
US-20200030488-A1 | Processes for coating inorganic particles with a peptide or protein useful for improving cellular activity related to bone growth | Active | 22-Feb-2018 | ||
US-11235086-B2 | Processes for coating inorganic particles with a peptide or protein useful for improving cellular activity related to bone growth | Active | 22-Feb-2018 | ||
EP-3530294-A1 | Processes for coating inorganic particles with a peptide or protein useful for improving cellular activity related to bone growth | Inactive | 22-Feb-2018 | ||
AU-2023216832-A1 | Peptide-coated calcium phosphate particles | Pending | 25-Jul-2016 | A61K35/32 |
Cerapedics Signals
Cerapedics Investors (8)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Miraki Innovation | Venture Capital | Minority | ||
KCK Group | Family Office | Minority | ||
KCK MedTech | Venture Capital | Minority | ||
KCK Capital | Venture Capital | Minority | ||
KOFA Healthcare | Venture Capital | Minority |
Cerapedics FAQs
-
When was Cerapedics founded?
Cerapedics was founded in 2001.
-
Where is Cerapedics headquartered?
Cerapedics is headquartered in Westminster, CO.
-
What is the size of Cerapedics?
Cerapedics has 206 total employees.
-
What industry is Cerapedics in?
Cerapedics’s primary industry is Biotechnology.
-
Is Cerapedics a private or public company?
Cerapedics is a Private company.
-
What is Cerapedics’s current revenue?
The current revenue for Cerapedics is
. -
How much funding has Cerapedics raised over time?
Cerapedics has raised $392M.
-
Who are Cerapedics’s investors?
Miraki Innovation, KCK Group, KCK MedTech, KCK Capital, and KOFA Healthcare are 5 of 8 investors who have invested in Cerapedics.
-
Who are Cerapedics’s competitors?
IlluminOss, Encoll, Spine Wave, MicroCures, and Centrexion Therapeutics are some of the 16 competitors of Cerapedics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »